Statistics for OR13-2 Burosumab Resulted in Greater Improvement in Rickets Than Conventional Therapy in Children with X-Linked Hypophosphatemia (XLH)

Total visits

views
OR13-2 Burosumab Resulted in Greater Improvement in Rickets Than Conventional Therapy in Children with X-Linked Hypophosphatemia (XLH) 170

Total visits per month

views
January 2024 0
February 2024 0
March 2024 0
April 2024 0
May 2024 0
June 2024 0
July 2024 0

File Visits

views
OR13-2 Burosumab Resulted in Greater Improvement in Rickets Than Conventional T.pdf 147

Top country views

views
United States 136
Germany 5
Ukraine 5
United Kingdom 3
Canada 2
China 2
Malaysia 1

Top city views

views
Wilmington 47
Fairfield 22
Cambridge 12
Ann Arbor 10
Houston 10
Jacksonville 5
Kiev 5
Kiez 3
Beijing 2
Seattle 2
Toronto 2
Baltimore 1
Bloomsbury 1
Brooklyn 1
Elmshorn 1
Gunzenhausen 1
Irvine 1
Mount Laurel 1
San Francisco 1
Scottsdale 1
Seremban 1